Cooper C. Collins, Chief Strategic Officer, 10% Owner at PERNIX THERAPEUTICS HOLDINGS, INC. (PTX), sold 90,000 shares at $1.99 ($180K) on 2013-11-05, disclosed to the SEC on 2013-11-05.
Scheduled sale ($180k) by Chief Strategic Officer, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.01 | 44,561 | $90K | 49.7% |
| 2 | $2.01 | 15,200 | $31K | 16.9% |
| 3 | $1.99 | 30,239 | $60K | 33.4% |
| Total | $2.00 avg | 90,000 | $180K | 100% |
| Filing → |
| TXMD | BUY | 2021-11-22 | $580K | — | Filing → |
| TXMD | BUY | 2021-08-19 | $725K | — | Filing → |
| TXMD | BUY | 2020-06-10 | $107K | — | Filing → |